|
|
|
Company
Name |
Short
Summary |
| Alexza Pharmaceuticals |
Alexza Pharmaceuticals is a rapidly emerging pharmaceutical development company focused on acute treatment of central nervous system, or CNS conditions. |
| Amunix |
The primary focus of Amunix is the design and early development of protein pharmaceuticals with an extended serum half-life, which may require less frequent administration. |
| Bavarian Nordic |
Bavarian Nordic is focused on vaccines for the treatment and prevention of cancer and infectious diseases. |
| Broncus Technologies |
Broncus Technologies is focused on the development and commercialization of products for diagnosing and treating lung diseases. |
| Cellecta |
Cellecta is focused on providing custom and contract solutions for high-throughput genetic screening. |
| ChemoCentryx |
ChemoCentryx is focused on development of oral small molecule therapeutics that target either chemokine receptors or chemoattractant receptors. |
| EGeen International |
EGeen International is focused on providing drug development services for clients in the biotechnology and pharmaceutical industries. |
| Hansen Medical |
Hansen Medical is focused on the development and commercialization of medical robotics. |
| IRIDEX |
IRIDEX is focused on the development and commercialization of light-based medical systems and delivery devices. |
| MedImmune |
MedImmune
is a biotechnology company formed to market products
for infectious diseases and transplantation medicine. |
| Progenitor Cell Therapy |
Progenitor Cell Therapy is focused on providing cGMP-compliant cell manufacturing and consulting services. |
| SanBio |
SanBio is focused on regenerative therapies for stroke, spinal cord injury, Parkinson's disease and multiple sclerosis. |
| Trigemina |
Trigemina is focused on the research and development of analgesics delivered through nasal-cerebral pathways. |
| Vivus |
VIVUS
is developing and commercializing advanced therapeutic
systems for the treatment of erectile dysfunction,
commonly referred to as impotence. The company's
core technology, the transurethral system for
erection, is based on the discovery that the urethra,
although an excretory duct, can absorb certain
pharmacologic agents into the surrounding erectile
tissues. |
